Therefore, although it is recommended to conduct cascade screening among family members of FH index cases, it may not sufficient to only determine and manage relatives who are FH positive without further investigating risk factors for CAD, which include biomarkers reflecting atherogenesis, in all relatives to identify those at risk for CAD despite being FH negative. Here, FH is linked to coronary artery disorder.